{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:00:58Z","timestamp":1790863258122,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Children\u2019s Foundation","award":["R1-2017-14"],"award-info":[{"award-number":["R1-2017-14"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Immune cytopenias, such as autoimmune hemolytic anemia, immune thrombocytopenia, and Evans syndrome, are characterized by autoantibodies targeting various blood cells, initiating their destruction. Interactions between T cells, B cells, their ultimate maturational plasma cell descendants, dendritic cells, and macrophages result in antibody production, including the autoreactive ones. Autoimmune phenomena can be idiopathic or associated with various immune dysregulation conditions or malignancies. Interventions disrupting this complex network at different levels have been used to treat immune cytopenias with certain levels of success. Some cases are known to be refractory to many different therapeutic approaches, including the ones eliminating B cells. In some such cases, targeting plasma cells resulted in disease control. Among plasma cell compartments, unique long-lived plasma cells (LLPCs) residing primarily in the bone marrow, are specialized antibody-producing cells with an extended lifespan, capable of persistently secreting antibodies. LLPCs can evade conventional therapeutic strategies designed to target often-proliferating cells. Research focusing on the role of LLPCs in autoimmune phenomena including immune cytopenias has provided evidence for their role, characterized by the sustained production of autoantibodies. Frequent genetic mutations and progression to other immune dysregulation entities have been reported in a group of children with immune cytopenias. This might provide new insights focusing on the potential underlying genetic and epigenetic mechanisms leading to generation and maintenance of LLPCs in autoimmune disorders. We provide a brief review of LLPC biology and evidence for their role in immune cytopenias with potential future implications in this article.<\/jats:p>","DOI":"10.3390\/cancers17091537","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:10:32Z","timestamp":1746076232000},"page":"1537","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Room for Long-Lived Plasma Cell Contribution in Immune Cytopenias?"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1467-4128","authenticated-orcid":false,"given":"Tricia","family":"Don","sequence":"first","affiliation":[{"name":"Pediatric Residency, Children\u2019s Hospital of Michigan, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-9487","authenticated-orcid":false,"given":"Manisha","family":"Gadgeel","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Flow Cytometry Laboratory, Children\u2019s Hospital of Michigan, Detroit, MI 48201, USA"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Saginaw, MI 48602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-3027","authenticated-orcid":false,"given":"S\u00fcreyya","family":"Sava\u015fan","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Flow Cytometry Laboratory, Children\u2019s Hospital of Michigan, Detroit, MI 48201, USA"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Saginaw, MI 48602, USA"},{"name":"Division of Hematology\/Oncology, Pediatric Transplantation and Cell Therapy Program, Children\u2019s Hospital of Michigan, Detroit, MI 48201, USA"},{"name":"Barbara Ann Karmanos Cancer Center, Detroit, MI 48201, USA"},{"name":"Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e28725","DOI":"10.1002\/pbc.28725","article-title":"Bortezomib treatment of steroid-refractory Evans syndrome in children","volume":"67","author":"Beydoun","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_2","unstructured":"Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001). Immunobiology: The Immune System in Health and Disease, Garland Pub."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","volume":"20","author":"Allman","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_4","unstructured":"Cano, R.L.E., and Lopera, H.D.E. (2013, July 18). Introduction to T and B lymphocytes, Autoimmunity: From Bench to Bedside, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459471\/."},{"key":"ref_5","unstructured":"Mourad, A., and Aribi, M. (2020). Normal and Malignant B-Cell, IntechOpen."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.11.017","article-title":"B-1 B cell development in the fetus and adult","volume":"36","author":"Dorshkind","year":"2012","journal-title":"Immunity"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: How they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","article-title":"Sites and stages of autoreactive B cell activation and regulation","volume":"28","author":"Shlomchik","year":"2008","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e150985","DOI":"10.1172\/JCI150985","article-title":"Positive and negative selection shape the human naive B cell repertoire","volume":"132","author":"Chen","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hofmann, K., Clauder, A.K., and Manz, R.A. (2018). Targeting B Cells and Plasma Cells in Autoimmune Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00835"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.2021012924","article-title":"T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome","volume":"139","author":"Kumar","year":"2022","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","article-title":"Strategies to guide the antibody affinity maturation process","volume":"11","author":"Joyce","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.imlet.2019.06.009","article-title":"Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches","volume":"212","author":"Tabasinezhad","year":"2019","journal-title":"Immunol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma","volume":"110","author":"Gonzalez","year":"2007","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T Cell Development, Localization, and Function throughout Life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lobo, P.I. (2016). Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00198"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e153580","DOI":"10.1172\/JCI153580","article-title":"High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura","volume":"132","author":"Crickx","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1615\/CritRevImmunol.2014012168","article-title":"Plasma cell formation, secretion, and persistence: The short and the long of it","volume":"34","author":"Bayles","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2017-01-761643","article-title":"CD138 mediates selection of mature plasma cells by regulating their survival","volume":"129","author":"McCarron","year":"2017","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"Raman","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nguyen, D.C., Joyner, C.J., Sanz, I., and Lee, F.E. (2019). Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02138"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjh.18773","article-title":"B cells and antibodies in refractory immune thrombocytopenia","volume":"203","author":"Roeser","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2149675","DOI":"10.1002\/eji.202149675","article-title":"Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches","volume":"53","author":"Frazzei","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pacillo, L., Giardino, G., Amodio, D., Giancotta, C., Rivalta, B., Rotulo, G.A., Manno, E.C., Cifaldi, C., Palumbo, G., and Pignata, C. (2022). Targeted treatment of autoimmune cytopenias in primary immunodeficiencies. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.911385"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tan, J.H., Ahmad Azahari, A.H.S., Ali, A., and Ismail, N.A.S. (2023). Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia. Genes, 14.","DOI":"10.3390\/genes14030555"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3324\/haematol.2020.271106","article-title":"Long term follow-up of pediatric-onset Evans syndrome: Broad immunopathological manifestations and high treatment burden","volume":"107","author":"Pincez","year":"2022","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjh.13866","article-title":"How I Manage Evans Syndrome and AIHA Cases in Children","volume":"172","author":"Miano","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/bjh.16171","article-title":"Post-allogeneic transplant Evans syndrome successfully treated with daratumumab","volume":"187","author":"Blennerhassett","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.56875\/2589-0646.1108","article-title":"Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases","volume":"17","author":"Yang","year":"2023","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102724","DOI":"10.1016\/j.bcmd.2023.102724","article-title":"Daratumumab as a novel treatment option in refractory ITP","volume":"99","author":"Vernava","year":"2023","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJMc2408786","article-title":"BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease","volume":"391","author":"Hagen","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood.2019003686","article-title":"How I manage autoimmune cytopenias in patients with lymphoid cancer","volume":"139","author":"Porpaczy","year":"2022","journal-title":"Blood"},{"key":"ref_34","first-page":"e5969","article-title":"A Case of Multiple Myeloma Presenting with Gastrointestinal Bleeding and Evans Syndrome","volume":"11","author":"Khan","year":"2019","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Barcellini, W., Giannotta, J.A., and Fattizzo, B. (2021). Autoimmune Complications in Hematologic Neoplasms. Cancers, 13.","DOI":"10.3390\/cancers13071532"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","article-title":"Autoimmune hemolytic anemias, Evans\u2019 syndromes, and pure red cell aplasia in non-Hodgkin lymphomas","volume":"48","author":"Hauswirth","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2011.02.004","article-title":"Paraneoplastic autoimmune thrombocytopenia in solid tumors","volume":"81","author":"Krauth","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101806","DOI":"10.1016\/j.canep.2020.101806","article-title":"Cancer risk in patients with primary immune thrombocytopenia\u2014A Swedish nationwide register study","volume":"69","author":"Ekstrand","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: Pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/bloodadvances.2023009949","article-title":"Deciphering the genetic basis of immune thrombocytopenia: Current evidence for genetic predisposition in adult ITP","volume":"7","author":"Georgi","year":"2023","journal-title":"Blood Adv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e31239","DOI":"10.1002\/pbc.31239","article-title":"Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome","volume":"71","author":"Bussel","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26508\/lsa.202101285","article-title":"Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting","volume":"5","author":"Joyner","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41423-022-00933-7","article-title":"Epigenetic regulation of B cells and its role in autoimmune pathogenesis","volume":"19","author":"Xiao","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-018-04234-4","article-title":"B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation","volume":"9","author":"Barwick","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","article-title":"XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation","volume":"21","author":"Shaffer","year":"2004","journal-title":"Immunity"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12975","article-title":"Epigenetic gene regulation in plasma cells","volume":"303","author":"Patterson","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ped4.12309","article-title":"The role of epigenetics in childhood autoimmune diseases with hematological manifestations","volume":"6","author":"Gkoutsias","year":"2022","journal-title":"Pediatr. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3324\/haematol.2013.097907","article-title":"Understanding the multiple biological aspects leading to myeloma","volume":"99","author":"Boyle","year":"2014","journal-title":"Haematologica"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/9\/1537\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:25:42Z","timestamp":1760030742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/9\/1537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cancers17091537"],"URL":"https:\/\/doi.org\/10.3390\/cancers17091537","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}